NMIH vs RARE · P/E 8.2, rev $651.0M vs rev $560.2M
NMI Holdings Inc (NMIH) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
NMI Holdings Inc (NMIH) is a insurance - specialty company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported NMIH revenue for 2024-12-31 was $651.0M. Net income was $360.1M. Revenue was up 12.4% from 2023-12-31 to 2024-12-31. NMIH currently screens at market cap $2.96B and trailing P/E 8.2.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
NMIH currently screens at market cap $2.96B and trailing P/E 8.2. RARE currently screens at market cap $2.79B.
Not investment advice. Open the NMIH and RARE stock pages for the full models.
Not investment advice.